Webinars » Maximizing PK and ADA Evaluation Efficiency with Our Cutting-Edge Rabbit Antibody Development Technology

Maximizing PK and ADA Evaluation Efficiency with Our Cutting-Edge Rabbit Antibody Development Technology

Rabbits possess a robust and unique immune system that generates antibodies with superior specificity, affinity, and diversity compared to rodents. This makes them highly recommended for producing high-quality antibodies. In the dynamic field of pharmaceutical development, the need for high precision and rigorous safety validation is critical to ensuring the efficacy and safety of new therapeutics. Therefore, anti-idiotypic antibodies (Anti-ID Abs) play a crucial role in this process by binding to therapeutic drugs in biological fluids, facilitating drug validation and safety evaluation. They are commonly used in pharmacokinetics (PK) and pharmacodynamics (PD) assays to assess drug efficacy and are instrumental in evaluating drug safety through anti-drug antibody (ADA) assays, which measure immunogenicity.

With over 20 years of antibody discovery experiences, GenScript offers multiple advanced platforms and flexible guaranteed or customized services for anti-ID Ab development. Currently, Our rabbit anti-ID antibody development service offers top-quality results at a price that’s comparable to mouse anti-ID mAb!

In this webinar, you will learn:

Overview of anti-ID antibodies

Why rabbits are the preferred host for generating high-performance anti-ID antibodies

GenScript’s rabbit anti-ID antibodies discovery strategies and capabilities

In this webinar, you will learn

Webinar Details

  • Date: October 18th , 2024
  • Time: 10:00 am EDT (NA) / 3:00pm BST (UK) / 4:00pm CEST (EU-Central)
Dr. Hui Foon Tan Dr. Hui Foon Tan

Sr. Global Product Manager - Antibody, GenScript Biotech

Hui Foon Tan is a Global Product Manager who supports GenScript antibody production service currently. She graduated with her Ph.D. in Biological Sciences from Nanyang Technological University, Singapore and continued to work as a Postdoctoral Research Fellow in cancer research for another 2 years. After she joins GenScript, Dr. Tan supports proteins and antibody production services in APAC region for a year. She provides application support for pre- and post-sale activities for services, updates and seminars to support co-stakeholders, distributors and customers. Currently, she is supporting new services launching and training in antibody production services. She also collates market dynamics and competitive market information from the field to understand the global market trends and collaborate with the team.

Speaker-related Webinars

Latest Webinars

Find More Antibody Categories »

Maximizing PK and ADA Evaluation Efficiency with Our Cutting-Edge Rabbit Antibody Development Technology

Maximizing PK and ADA Evaluation Efficiency with Our Cutting-Edge Rabbit Antibody Development Technology

Accelerating Therapeutic Antibody Development: Discover Our Cutting-Edge CHO Expression Technology

Accelerating Therapeutic Antibody Development: Discover Our Cutting-Edge CHO Expression Technology

Bispecific Antibody Overview & CrossMab Technology | GenScript

Bispecific Antibody Overview & CrossMab Technology | GenScript